Transmyocardial Revascularization (TMR)
utilizing a Holmium:YAG laser was approved by the FDA for the treatment
of severe angina in patients whose chronic angina symptoms are not
relived by medication and have an area of the heart that cannot be
treated by percutaneous intervention or bypass surgery.
3 out of 4 patients who received TMR in studies, have shown a significant reduction in their angina pain1
These important patient benefits have been shown to endure beyond five years, and may help patients live longer2
TMR is reimbursed by Medicare and Blue Cross/Blue Shield when performed
as a stand alone procedure and when performed as a compliment to bypass
surgery.
|
|
Allen,
K.B., et al. “Comparison of Transmyocardial Revascularization with
Medical Therapy in Patients with Refractory Angina.” N Eng Journal
Medicine 1999; 341(14):1029-36. |
| |
|
|
|
Allen,
K.B., et al. “Transmyocardial Revascularization: 5-Year Follow-Up of a
Prospective, Randomized Multicenter Trial.” Ann Thorac Surg
2004;77:1228-1234. |